版本:
中国

BRIEF-Celsion corp gets positive DSMB review of Phase Ib ovation study

Sept 15 Celsion Corp

* Says future studies of GEN-1 will include a phase I/II study combining GEN-1 with avastin and doxil

* Celsion corporation announces positive DSMB review of Phase 1b ovation study in ovarian cancer

* Says expects to report full data from ovation study by Q1 of 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐